Cortical asymmetries in normal, mild cognitive impairment, and Alzheimer's disease

Jong Hun Kim; Jong Weon Lee; Geon Ha Kim; Jee Hoon Roh; Min Jeong Kim; Sang Won Seo; Sung Tae Kim; Seun Jeon; Jong Min Lee; Kenneth M. Heilman; Duk L. Na

doi:10.1016/j.neurobiolaging.2011.06.026

Cortical asymmetries in normal, mild cognitive impairment, and Alzheimer's disease

Jong Hun Kim, Jong Weon Lee, Geon Ha Kim, Jee Hoon Roh, Min Jeong Kim, Sang Won Seo, Sung Tae Kim, Seun Jeon, Jong Min Lee, Kenneth M. Heilman, Duk L. Na

Department of Neurology

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Abstract

There are functional and structural neocortical hemispheric asymmetries in people with normal cognition. These asymmetries may be altered in patients with Alzheimer's disease (AD) because there is a loss of neuronal connectivity in the heteromodal cortex. The purpose of this study is to test the hypothesis that individuals with amnestic mild cognitive impairment (aMCI), mild AD, and moderate to severe AD have progressive reductions in thickness asymmetries of the heteromodal neocortex. Right-handed elderly volunteers including normal cognition (NC), aMCI, and AD underwent 3-D volume imaging for cortical thickness. Although the cortical asymmetry pattern observed in normal cognition brains was generally maintained in aMCI and AD, there was a progressive decrease in the degree of asymmetry, especially in the inferior parietal lobule. A reduction of neocortical asymmetries may be a characteristic sign that occurs in patients with AD. Future studies are needed to evaluate whether this loss is specific to AD and if measurements of asymmetry can be used as diagnostic markers and for monitoring disease progression.

Original language	English
Pages (from-to)	1959-1966
Number of pages	8
Journal	Neurobiology of Aging
Volume	33
Issue number	9
DOIs	https://doi.org/10.1016/j.neurobiolaging.2011.06.026
State	Published - Sep 2012

Bibliographical note

Funding Information:
This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea ( A050079 ).

Funding Information:
Dr. Heilman receives research support from the state of Florida, NIDCD/NIH (T-32 grant, 1T32DC008768-01 ), VA-Merit Review (#114-30-4813), University of Florida Opportunity Fund and NIH ( R21 DC009247 ). Also, he was sponsored by Myriad, Novartis, Esai, and Pfizer Pharmaceuticals, Inc., for drug studies. The remaining authors report no disclosures.

Keywords

Alzheimer's disease
Cerebral asymmetry
Cortical thickness
Mild cognitive impairment

Access to Document

10.1016/j.neurobiolaging.2011.06.026

Cite this

@article{3937226871ba4eb39e21a1535874b581,

title = "Cortical asymmetries in normal, mild cognitive impairment, and Alzheimer's disease",

abstract = "There are functional and structural neocortical hemispheric asymmetries in people with normal cognition. These asymmetries may be altered in patients with Alzheimer's disease (AD) because there is a loss of neuronal connectivity in the heteromodal cortex. The purpose of this study is to test the hypothesis that individuals with amnestic mild cognitive impairment (aMCI), mild AD, and moderate to severe AD have progressive reductions in thickness asymmetries of the heteromodal neocortex. Right-handed elderly volunteers including normal cognition (NC), aMCI, and AD underwent 3-D volume imaging for cortical thickness. Although the cortical asymmetry pattern observed in normal cognition brains was generally maintained in aMCI and AD, there was a progressive decrease in the degree of asymmetry, especially in the inferior parietal lobule. A reduction of neocortical asymmetries may be a characteristic sign that occurs in patients with AD. Future studies are needed to evaluate whether this loss is specific to AD and if measurements of asymmetry can be used as diagnostic markers and for monitoring disease progression.",

keywords = "Alzheimer's disease, Cerebral asymmetry, Cortical thickness, Mild cognitive impairment",

author = "Kim, {Jong Hun} and Lee, {Jong Weon} and Kim, {Geon Ha} and Roh, {Jee Hoon} and Kim, {Min Jeong} and Seo, {Sang Won} and Kim, {Sung Tae} and Seun Jeon and Lee, {Jong Min} and Heilman, {Kenneth M.} and Na, {Duk L.}",

note = "Funding Information: This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea ( A050079 ). Funding Information: Dr. Heilman receives research support from the state of Florida, NIDCD/NIH (T-32 grant, 1T32DC008768-01 ), VA-Merit Review (#114-30-4813), University of Florida Opportunity Fund and NIH ( R21 DC009247 ). Also, he was sponsored by Myriad, Novartis, Esai, and Pfizer Pharmaceuticals, Inc., for drug studies. The remaining authors report no disclosures. ",

year = "2012",

month = sep,

doi = "10.1016/j.neurobiolaging.2011.06.026",

language = "English",

volume = "33",

pages = "1959--1966",

journal = "Neurobiology of Aging",

issn = "0197-4580",

publisher = "Elsevier Inc.",

number = "9",

}

TY - JOUR

T1 - Cortical asymmetries in normal, mild cognitive impairment, and Alzheimer's disease

AU - Kim, Jong Hun

AU - Lee, Jong Weon

AU - Kim, Geon Ha

AU - Roh, Jee Hoon

AU - Kim, Min Jeong

AU - Seo, Sang Won

AU - Kim, Sung Tae

AU - Jeon, Seun

AU - Lee, Jong Min

AU - Heilman, Kenneth M.

AU - Na, Duk L.

N1 - Funding Information: This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea ( A050079 ). Funding Information: Dr. Heilman receives research support from the state of Florida, NIDCD/NIH (T-32 grant, 1T32DC008768-01 ), VA-Merit Review (#114-30-4813), University of Florida Opportunity Fund and NIH ( R21 DC009247 ). Also, he was sponsored by Myriad, Novartis, Esai, and Pfizer Pharmaceuticals, Inc., for drug studies. The remaining authors report no disclosures.

PY - 2012/9

Y1 - 2012/9

N2 - There are functional and structural neocortical hemispheric asymmetries in people with normal cognition. These asymmetries may be altered in patients with Alzheimer's disease (AD) because there is a loss of neuronal connectivity in the heteromodal cortex. The purpose of this study is to test the hypothesis that individuals with amnestic mild cognitive impairment (aMCI), mild AD, and moderate to severe AD have progressive reductions in thickness asymmetries of the heteromodal neocortex. Right-handed elderly volunteers including normal cognition (NC), aMCI, and AD underwent 3-D volume imaging for cortical thickness. Although the cortical asymmetry pattern observed in normal cognition brains was generally maintained in aMCI and AD, there was a progressive decrease in the degree of asymmetry, especially in the inferior parietal lobule. A reduction of neocortical asymmetries may be a characteristic sign that occurs in patients with AD. Future studies are needed to evaluate whether this loss is specific to AD and if measurements of asymmetry can be used as diagnostic markers and for monitoring disease progression.

AB - There are functional and structural neocortical hemispheric asymmetries in people with normal cognition. These asymmetries may be altered in patients with Alzheimer's disease (AD) because there is a loss of neuronal connectivity in the heteromodal cortex. The purpose of this study is to test the hypothesis that individuals with amnestic mild cognitive impairment (aMCI), mild AD, and moderate to severe AD have progressive reductions in thickness asymmetries of the heteromodal neocortex. Right-handed elderly volunteers including normal cognition (NC), aMCI, and AD underwent 3-D volume imaging for cortical thickness. Although the cortical asymmetry pattern observed in normal cognition brains was generally maintained in aMCI and AD, there was a progressive decrease in the degree of asymmetry, especially in the inferior parietal lobule. A reduction of neocortical asymmetries may be a characteristic sign that occurs in patients with AD. Future studies are needed to evaluate whether this loss is specific to AD and if measurements of asymmetry can be used as diagnostic markers and for monitoring disease progression.

KW - Alzheimer's disease

KW - Cerebral asymmetry

KW - Cortical thickness

KW - Mild cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=84863432595&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2011.06.026

DO - 10.1016/j.neurobiolaging.2011.06.026

M3 - Article

C2 - 21907459

AN - SCOPUS:84863432595

SN - 0197-4580

VL - 33

SP - 1959

EP - 1966

JO - Neurobiology of Aging

JF - Neurobiology of Aging

IS - 9

ER -

Cortical asymmetries in normal, mild cognitive impairment, and Alzheimer's disease

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this